欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FI/H/1094/002
药品名称Lugesteron
活性成分
    • progesterone 400.0 mg
剂型Vaginal capsule, soft
上市许可持有人Besins Healthcare Ireland Ltd. 16 Pembroke Street Upper DUBLIN 2, D02 HE63 IRELAND
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Norway (NO)
    • Austria (AT)
    • Belgium (BE)
    • Bulgaria (BG)
      Utrogestan
    • Germany (DE)
      Utrogest Luteal 400 mg
    • Estonia (EE)
    • Croatia (HR)
    • Hungary (HU)
    • Ireland (IE)
    • Latvia (LV)
    • Luxembourg (LU)
    • Sweden (SE)
      Utrogestan
    • Slovenia (SI)
    • Slovakia (SK)
    • United Kingdom (Northern Ireland) (XI)
    • Poland (PL)
    • Lithuania (LT)
    • Netherlands (NL)
    • Czechia (CZ)
许可日期2021/03/24
最近更新日期2021/05/18
药物ATC编码
    • G03DA04 progesterone
申请类型
  • TypeLevel1：Line Extension
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Withdrawn（注：已撤市）
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase